DE MURO, Pierina
 Distribuzione geografica
Continente #
NA - Nord America 3.767
AS - Asia 2.382
EU - Europa 1.407
SA - Sud America 1.300
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 44
OC - Oceania 7
Totale 8.993
Nazione #
US - Stati Uniti d'America 3.688
BR - Brasile 1.157
CN - Cina 849
SG - Singapore 849
UA - Ucraina 526
HK - Hong Kong 230
DE - Germania 192
IT - Italia 169
FR - Francia 150
VN - Vietnam 148
SE - Svezia 100
FI - Finlandia 87
GB - Regno Unito 76
TR - Turchia 59
AR - Argentina 52
CA - Canada 33
BD - Bangladesh 31
IQ - Iraq 31
ZA - Sudafrica 30
IN - India 26
MX - Messico 26
BE - Belgio 24
PK - Pakistan 24
VE - Venezuela 24
EC - Ecuador 22
KR - Corea 20
RU - Federazione Russa 19
UZ - Uzbekistan 18
MA - Marocco 17
JP - Giappone 16
PL - Polonia 15
CL - Cile 12
ID - Indonesia 12
CO - Colombia 10
ES - Italia 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
DZ - Algeria 8
EU - Europa 8
PE - Perù 8
PY - Paraguay 8
JO - Giordania 7
NP - Nepal 7
AU - Australia 6
IL - Israele 6
NL - Olanda 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EG - Egitto 5
LB - Libano 5
OM - Oman 5
PH - Filippine 5
AT - Austria 4
GR - Grecia 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
GE - Georgia 3
JM - Giamaica 3
LT - Lituania 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
Totale 8.952
Città #
Dallas 972
Singapore 483
Chandler 435
Jacksonville 316
San Jose 242
Hong Kong 229
Ashburn 164
Princeton 158
Beijing 149
Nanjing 147
Council Bluffs 114
Dearborn 104
Columbus 91
São Paulo 88
New York 86
Ann Arbor 83
Wilmington 72
Lauterbourg 70
Nanchang 65
Sassari 61
Ho Chi Minh City 54
Shanghai 45
Boardman 44
Shenyang 43
Hebei 39
Rio de Janeiro 39
Los Angeles 36
Santa Clara 33
Woodbridge 31
Belo Horizonte 30
Changsha 30
Tianjin 30
Hanoi 28
Ningbo 26
Izmir 25
Brussels 24
Campinas 23
Mountain View 22
Curitiba 21
Hangzhou 21
Johannesburg 21
Seoul 20
Buffalo 19
Jinan 19
Orem 18
Zhengzhou 18
Jiaxing 17
Tashkent 17
Tokyo 15
Baghdad 14
Brasília 14
Kunming 14
Toronto 14
Warsaw 14
Andover 13
Norwalk 13
San Francisco 13
Goiânia 12
London 11
Brooklyn 10
Guangzhou 10
Guarulhos 10
Haiphong 10
Porto Alegre 10
Ribeirão Preto 10
Sorocaba 10
The Dalles 10
Betim 9
Cagliari 9
Casablanca 9
Helsinki 9
Atlanta 8
Caxias do Sul 8
Chennai 8
Da Nang 8
Denver 8
Manaus 8
Manchester 8
Montreal 8
Nairobi 8
Phoenix 8
Quito 8
Stockholm 8
São José dos Campos 8
Campo Grande 7
Fortaleza 7
Frankfurt am Main 7
Osasco 7
Recife 7
Santo André 7
Villiers-sur-marne 7
Americana 6
Amman 6
Auburn Hills 6
Blumenau 6
Boston 6
Buenos Aires 6
Carapicuíba 6
Dhaka 6
Florianópolis 6
Totale 5.392
Nome #
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 205
Apolipoprotein Profiles in Atherosclerotic Disease 183
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 172
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 158
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 156
Apolipoprotein Profiles in Atherosclerotic Disease 155
A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients 149
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 149
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 142
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 141
Buoyant density of Lp(a) subclasses in hypercholesterolemia 140
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 139
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 137
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 137
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 136
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 136
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 135
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 132
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 131
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 130
Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity 129
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 128
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 126
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 126
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 125
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 123
Sulphated polysaccharide content and localization in some marine sponge species. 123
Urinary glycosaminoglycan composition in chronic glomerulonephritis 123
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 122
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 121
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 117
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 117
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 116
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 113
Hb G-Philadelphia, or [alpha68(E17)AsnLys], in North Sardinia: detection by isoelectric focusing and HPLC of tryptic peptides 112
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 112
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 109
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 109
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 109
Glycosamynoglycan diversity in sponge extracellular matrix 108
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 107
Urine bikunin as a marker of renal impairment in Fabry's disease 107
Atherosclerotic modifications of human proteoglycans 106
GAG and protein composition of GAG-protein complexes from normal human plasma 105
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 104
Haematological and biosynthetic features of beta°-thalassemia with an associated alpha-thalassemia heterozygosity in Sardinia 103
Ruolo dei proteoglicani nella medicina della riproduzione 103
Role of the small proteoglycan bikunin in human reproduction 102
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 102
Urinary transforming growth factor-beta 1 in various types of nephropathy 100
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 100
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 100
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 100
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 99
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 96
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 96
Urinary excretion of GAGs during hypocholesterolemic therapy 96
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 96
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 95
Urinary transaforming growth factor beta 1 in various types of nephropathy 94
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 93
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 92
Proteoglicani e diabete gestazionale: dati preliminari 89
The gamma globin chain heterogeneity of the Sardinian newborn baby 88
Urinary glycosaminoglycansin patients with systemic lupus erytematosus 87
Modification of low density lipoprotein induced by the interaction with standard GAGs 87
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 87
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 86
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 85
Hematological and biosynthetic features of betao-thalassemia with an associated beta-thalassemia heterozygosity in Sardinia. 84
Investigations on PGs extracted from human aorta of different age and with different atherosclerotic lesions 81
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 81
Glycosaminoglycans and fabry’s disease 80
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 79
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 78
Human LDL binding to plasma high charge glycosaminoglycan-protein complexes 78
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 76
Glycosaminoglycan diversity in sponge extracellular matrix 75
Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes 73
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 72
Totale 8.993
Categoria #
all - tutte 37.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022334 0 3 0 11 6 2 24 26 46 25 39 152
2022/2023802 84 54 14 149 82 141 0 93 130 9 28 18
2023/2024227 45 19 7 4 48 50 1 11 0 1 23 18
2024/20252.307 18 17 128 30 110 48 192 368 827 403 108 58
2025/20262.903 119 774 351 376 264 204 356 98 150 135 56 20
2026/2027276 65 211 0 0 0 0 0 0 0 0 0 0
Totale 8.993